For muscle cramping, clinicians should first assess for electrolyte abnormalities, including magnesium, calcium, and potassium, before considering supplementation
While contextual data confirms cardiovascular safety for tirzepatide against dulaglutide, definitive head-to-head cardiovascular outcomes comparing the two agents directly remain unestablished
However, patients may experience minor side effects, such as injection site reactions (redness, swelling, or itching) or gastrointestinal symptoms (nausea, vomiting, or diarrhea)
PlexusDx supports this transition with ongoing provider guidance and genetic insights that explain your unique metabolic tendencies, making behavioral change feel more achievable and permanent